IDXX
Idexx Laboratories, Inc.

2,919
Mkt Cap
$50.22B
Volume
70,532.00
52W High
$688.12
52W Low
$356.14
PE Ratio
52.24
IDXX Fundamentals
Price
$631.77
Prev Close
$627.66
Open
$627.62
50D MA
$638.16
Beta
1.16
Avg. Volume
415,342.71
EPS (Annual)
$10.67
P/B
34.48
Rev/Employee
$354,318.54
Loading...
Loading...
News
all
press releases
Countdown to Idexx (IDXX) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for Idexx (IDXX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Zacks·1d ago
News Placeholder
More News
News Placeholder
ECL Stock Falls in Pre-Market Despite Q3 Earnings Beat, Margins Expand
Ecolab tops third-quarter 2025 estimates with strong margin gains and lifts full-year EPS outlook amid steady segment growth.
Zacks·2d ago
News Placeholder
Earnings Preview: PROCEPT BioRobotics Corporation (PRCT) Q3 Earnings Expected to Decline
PROCEPT BioRobotics (PRCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2d ago
News Placeholder
Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3d ago
News Placeholder
Bio-Techne Q1 Earnings Preview: What's in Store for the Stock?
TECH's Q1 results could reflect steady Protein Sciences growth but pressure in Spatial Biology amid NIH and biotech funding uncertainty.
Zacks·7d ago
News Placeholder
BFLY Q3 Earnings Preview: Strategic Progress Likely to Support Growth
Butterfly Network's Q3 earnings may have been shaped by iQ3 adoption, software growth and strategic progress.
Zacks·8d ago
News Placeholder
STERIS to Report Q2 Earnings: Here's What to Expect
STE is set to post fiscal Q2 results on Nov. 6, with estimates pointing to solid revenue and earnings growth across key segments.
Zacks·8d ago
News Placeholder
HOLX or IDXX: Which Is the Better Value Stock Right Now?
HOLX vs. IDXX: Which Stock Is the Better Value Option?
Zacks·9d ago
News Placeholder
Zimmer Biomet to Report Q3 Earnings: Here's What to Expect
ZBH's Q3 results on Nov. 5 may show solid gains, driven by hip, knee, and S.E.T. segment growth and recent product approvals.
Zacks·9d ago
News Placeholder
ALGN Gears Up for Q3 Earnings: What Lies Ahead for the Stock?
Align Technology readies its Q3 report, with steady Clear Aligner demand and scanner upgrades expected to shape its performance.
Zacks·10d ago

Latest IDXX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.